Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2236 AL 2250

Targeting the NLRP3 inflammasome with antibody-based therapeutics for chronic neurodegenerative diseases

Sandhu JK, Tanha J, Arbabi-Ghahroudi M.

Expert Opin Ther Targets. 2026 Apr;30(4):309-328. doi: 10.1080/14728222.2026.2671675. Epub 2026 May 21.

Emerging Roles, Mechanisms, and Therapeutic Potential of Thyroid Hormones in Neurodegenerative Diseases: A Review

Li X, Li Z, Sun M, Du Y, Bai H, Chen X, Wang J.

Brain Sci. 2026 Feb 14;16(2):229. doi: 10.3390/brainsci16020229.

Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives

Kwaśniewska K, Fic W, Polak-Szczybyło E.

Nutrients. 2026 Mar 20;18(6):995. doi: 10.3390/nu18060995.

Neurobiology of exercise in Parkinson's disease

Rodriguez TN, Smeyne RJ, Smeyne M.

J Parkinsons Dis. 2026 May 20:1877718X261452869. doi: 10.1177/1877718X261452869. Online ahead of print.

Beyond Organ Boundaries: Molecular Mechanisms of Hepatic Encephalopathy and Parkinson's Disease from the Perspective of the Gut-Liver-Brain Axis

Liu T, Ma Y, Zhang M, Wei J.

Research (Wash D C). 2026 Feb 6;9:1084. doi: 10.34133/research.1084. eCollection 2026.

Small Extracellular Vesicles from Neural Cells: Physiological and Pathological Roles, and Potential in Neurodegenerative Therapy

Salim MW, Zhang W, Collins-Praino L, Wang Y, Care A.

Adv Healthc Mater. 2026 Apr 6:e04608. doi: 10.1002/adhm.202504608. Online ahead of print.

Co-aggregation of amyloidogenic proteins in age-related neurodegenerative diseases

Basha S, Nadkarni PP, Pai AR, Mahato KK.

Ageing Res Rev. 2026 Jun;118:103148. doi: 10.1016/j.arr.2026.103148. Epub 2026 Apr 22.

Neuroprotective role of phenolic acids: mechanistic insights into cognitive decline and neurodegenerative disorder

Balwant Patil K, Sugunan S, Padiyar A, Mishra AK, Jain S.

Nutr Neurosci. 2026 May 9:1-25. doi: 10.1080/1028415X.2026.2669234. Online ahead of print.

High intensity interval training for Parkinson's disease: A scoping review of systemic effects and physiological adaptations

Sivaramakrishnan A, Cascella M, Hauck S, Reyes NS, Vaou O.

J Parkinsons Dis. 2026 May;16(3):416-437. doi: 10.1177/1877718X261427268. Epub 2026 Mar 5.

Clinical GDNF delivery methods for Parkinson's disease

Luz M, Fiandaca MS, Bankiewicz KS.

J Parkinsons Dis. 2026 May 6:1877718X261444841. doi: 10.1177/1877718X261444841. Online ahead of print.

WWOX Mutation as a Rare Cause of Neonatal-Infantile Parkinsonism Mimicking a Neurotransmitter Disorder: A Case Report

Serce Pehlevan O, Gider Yaman G, Gok A, Tekin Orgun L.

J Paediatr Child Health. 2026 May 6. doi: 10.1111/jpc.70401. Online ahead of print.

Advances in Cardiolipin Analysis: Applications in Central Nervous System Disorders and Nutrition Interventions

Dong C, Lv D, Dong Y, Zhang Z, Li Q, Chen Z.

Biomolecules. 2026 Jan 1;16(1):71. doi: 10.3390/biom16010071.

Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives

Aslan FS, Barut B, Ozturk S, Eyigurbuz T, Akyuz E.

ACS Chem Neurosci. 2026 Apr 15;17(8):1432-1461. doi: 10.1021/acschemneuro.5c00809. Epub 2026 Mar 29.

Emerging Therapeutic Strategies for Neurodegenerative Diseases: A Comprehensive Review of Recent Advances and Future Directions

Sepehrimanesh M, Melen SV, Yeasmin F, Ojo VA, Walden F, Urmee H, Etheridge J, Nasu AK.

Cells. 2026 May 18;15(10):928. doi: 10.3390/cells15100928.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias